Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Business

Lancaster University spinout wins major backing to revolutionise healthcare diagnostics

by February 6, 2025
February 6, 2025
Lancaster University spinout wins major backing to revolutionise healthcare diagnostics

Lancaster-based startup CCI Photonics has secured significant new funding to develop its groundbreaking technology for rapid infection detection and antibiotic screening.

Launched by Lancaster University researchers, the spinout aims to deliver test results in as little as 15 minutes—dramatically faster than traditional methods, which can take up to 72 hours.

The investment pot includes £200,000 from the Northern Powerhouse Investment Fund II (NPIF II) PraeSeed programme, £150,000 from the Infection Innovation Consortium (iiCON), and £100,000 from Lyva Labs via Liverpool City Region Combined Authority. CCI Photonics has also received backing from ICURe Innovate UK and holds additional support through a UKRI Novel Technologies Grant.

At the heart of this innovation is InfectiScan, a powerful in vitro diagnostic device that uses infrared spectrometry and advanced AI models to pinpoint bacterial infections in bodily fluids—and determine the most effective antibiotics to prescribe. Founded on research undertaken in partnership with the University Hospitals of Morecambe Bay NHS Foundation Trust (UHMBT), the technology is designed to tackle antibiotic resistance by reducing the guesswork in prescribing antibiotics.

Current diagnostic tools often leave clinicians prescribing treatments on a “best guess” basis, contributing to the rise of antibiotic resistance and increasing the likelihood of ineffective care or infection recurrence. With CCI Photonics’ InfectiScan device, healthcare professionals will be able to rapidly identify pathogens and confirm antibiotic suitability, significantly improving patient outcomes.

Dr Meza Ramirez, Chief Executive of CCI Photonics, emphasised: “This funding allows us to take critical steps in validating and refining our technology. With the support of our partners, we are working to bring a practical solution to healthcare challenges.”

Professor Craig Williams, Consultant Microbiologist at UHMBT, echoed this sentiment: “I hope this ongoing research will provide much more rapid diagnosis, leading to better infection treatment outcomes at a time when bacteria are becoming more resistant to commonly used antibiotics.”

Professor Janet Hemingway, founding director of iiCON, also underlined the importance of disruptive technologies in the fight against infectious diseases, noting the urgent global health challenge and the need for swift innovation.

By combining world-class research, strong funding, and practical clinical collaboration, CCI Photonics is poised to transform infectious disease diagnostics—potentially slashing test turnaround times from days to minutes and helping to stave off the looming threat of antibiotic resistance.

Read more:
Lancaster University spinout wins major backing to revolutionise healthcare diagnostics

0
FacebookTwitterGoogle +Pinterest
previous post
BT scraps diversity targets from managers’ bonuses
next post
Re N Tox: Medical Spa RX Delivers a Breakthrough in Wrinkle Treatment

You may also like

Why Does Communication in Health and Social Care...

March 11, 2025

An In-Depth Conversation with Alison Schrag: Exploring Urban...

January 10, 2025

UK Inflation Holds Steady at 2.2%, Core Inflation...

September 18, 2024

20,000 people off work in the UK every...

March 15, 2024

How Virtual & Augmented Reality Could Change the...

March 23, 2025

The Twitter Exodus: are we coming or going?

November 14, 2022

The Importance of digital detoxing for busy working...

April 30, 2024

Taxpayers left with £421m bill after one in...

July 29, 2022

UK’s entrepreneurial ambitions stronger than ever as small...

June 9, 2023

Brompton’s profit plunges to less than the price...

January 3, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Disabling Trump’s “Tariff Button”

      June 5, 2025
    • ‘Sick puppy’ Tim Walz should never have been on Dems’ 2024 ticket, Trump says

      June 5, 2025
    • Federal judge orders Trump to restore funding to Clinton-era agency gutted by DOGE

      June 5, 2025
    • Musk says Trump would have lost 2024 election without him as ‘Big Beautiful Bill’ feud continues

      June 5, 2025
    • Ex-Biden adviser calls Jean-Pierre ‘kinda dumb,’ deletes tweet, says she’s not a ‘genius-level Black woman’

      June 5, 2025
    • ‘Coming for us’: Expert sounds alarm on CCP’s mission to ‘kill Americans’ after FBI makes shocking arrests

      June 5, 2025

    Categories

    • Business (8,148)
    • Investing (2,010)
    • Politics (15,535)
    • Stocks (3,128)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved